Pharmaceutical companies are developing new weight-loss treatments, including orforglipron, an oral pill that shows better efficacy than semaglutide in clinical trials. Participants lost more weight on orforglipron, but reported higher adverse effects. The pill is under FDA review and could be available for US patients at prices ranging from $149 to $399. Teljes cikk (Euronews.com)